Michael D. Hooven, Director at AtriCure, Inc. (ATRC), sold 20,000 shares at $22.08 ($442K) on 2017-05-05, disclosed to the SEC on 2017-05-09.
Open-market sale of $442k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.08 | 10,000 | $221K | 50.0% |
| 2 | $22.08 | 10,000 | $221K | 50.0% |
| Total | $22.08 avg | 20,000 | $442K | 100% |
| Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |
| ATRC | BUY | 2012-09-14 | $8K | — | Filing → |